Navigation Links
Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results
Date:2/13/2009

EVENUE $14,795,746 $24,954,288 $32,919,474 $44,327,357 COST OF SALES 12,801,591 19,086,274 27,732,778 33,865,306 GROSS PROFIT 1,994,155 5,868,014 5,186,696 10,462,051 SELLING, GENERAL AND ADMINISTRATIVE EXPENSES 2,322,885 1,814,376 4,752,675 3,510,931 INCOME (LOSS) FROM OPERATIONS (328,730) 4,053,638 434,021 6,951,120 OTHER INCOME (EXPENSE): Earnings on equity investment 31,561 977 33,412 149,756 Other income 43,312 69,962 55,181 109,709 Other expense (242,202) (26,495) (251,112) (203,844) Interest expense and other charges (41,667) (519,417) (63,506) (935,881) Interest income 79,380 32,243 96,673 98,404 Other income (expense), net (129,616) (442,730) (129,352) (781,856) INCOME (LOSS) BEFORE PROVISION FOR INCOME TAXES (458,346) 3,610,908 304,669 6,169,264 PROVISION FOR INCOME TAXES 15,541 481,323 148,760 787,168 NET INCOME (LOSS) (473,887) 3,129,585 155,909 5,382,096 OTHER COMPREHENSIVE INCOME: Foreign currency translation adjustments 123,453 140,556 287,726 1,412,651 COMPREHENSIVE INCOME (LOSS) $(350,434) $3,270,141 $443,635 $6,794,747 EARNINGS (LOSS) PER SHARE Basic $(0.02) $0.17 $0.01 $0.28 Diluted $(0.02) $0.15 $0.01 $0.27 WEIGHTED AVERAGE NUMBER OF SHARES Basic 19,123,338 18,961,992 19,109,149 18,918,496 Diluted 19,123,338 20,296,006
'/>"/>
SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008
2. Shengtai Pharmaceutical, Inc. Appoints New CFO
3. Shengtai Pharmaceutical Retains Grayling Global As Investor Relations Counsel
4. Shengtai Pharmaceutical Completes Factory Improvements Resulting in Operational and Environmental Benefits
5. Shengtai Pharmaceutical Schedules 2009 First Quarter Financial Results and Conference Call
6. DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board
7. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
9. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
10. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
11. Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 Vermillion, ... focused on gynecologic disease, announced today that investors ... , Birchview Fund LLC and several Vermillion directors ... unregistered shares of Vermillion,s common stock and warrants ... in a private placement.  Under ...
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014 /PRNewswire/ ... study of mazindol in children with attention deficit/hyperactivity disorder ... December 2014 . The paper, titled ... attention deficit/hyperactivity disorder" ( Konofal et al, ... eCollection 2014 ) shows that mazindol might be ...
(Date:12/22/2014)... , Dec. 22, 2014  Alternative Energy ... that it has signed a letter of intent ... has developed and patented a nanotechnology-based development platform ... products that enable rapid on-site collection and testing ... and health issues in an immediate, non-invasive and ...
(Date:12/22/2014)... Illinois (PRWEB) December 22, 2014 ITRA ... tenants and occupiers of commercial real estate, has further ... new offices in Perth and Brisbane, Western Australia, reports ... of directors. , ITRA Global / ACORPP (Australian ... totally independent consultancy company providing property services to a ...
Breaking Biology Technology:Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3ALNE Announces Intention To Acquire BioTechPharma 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2
... ... ... -- The American Medical Writers Association named medical writer, Rita Buckley, Writer/Owner of ... in Medical Communication. She received the awards for The Lehman Series Expert Panel on ...
... June 11, 2010 Researchers at Texas A&M University College ... first with the successful delivery of a foal using oocytes ... world. The delivery of the foal highlights Texas A&M,s long ... a great experience for the owner of the new foal., ...
... world,s smallest chess board about the diameter of ... winners in this year,s design contest for, respectively, novel ... Laboratories in mid May. The two winning teams ... one of the most advanced in the world. ...
Cached Biology Technology:Medical Writer Rita Buckley Wins Awards for Excellence in Medical Communication 2Medical Writer Rita Buckley Wins Awards for Excellence in Medical Communication 3Texas A&M veterinary researchers achieve cloning first 2Texas A&M veterinary researchers achieve cloning first 3Texas Tech, U of Utah win Sandia microdevice competition 2Texas Tech, U of Utah win Sandia microdevice competition 3Texas Tech, U of Utah win Sandia microdevice competition 4
(Date:12/19/2014)... --  LaunchKey , the first decentralized mobile authentication and ... Things era, today announced the close of $3 million ... by Metamorphic Ventures with participation from ENIAC Ventures, Crosslink ... LaunchKey has raised $4 million to date, and will ... bring LaunchKey to market in 2015. LaunchKey ...
(Date:12/17/2014)... Dec. 15, 2014  HITLAB SM announced ... (GCP) audit to confirm its adherence to current ... accomplishment enables HITLAB to conduct regulated smart device ... principles for patient safety and research quality. ... access, quality, and delivery with innovative technology," said ...
(Date:12/17/2014)... , Dec. 16, 2014  Automation is ... this more evident than at international borders. Over ... document scanners have allowed veteran travelers to self ... Passport Control (APC) Kiosks at an increasing number ... globe. According to Maxine ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
... embryo formation in the lowly fruit fly, a little ... to a study in the Oct. 14 Developmental ... While the fundamentals of this tiny bug,s reproductive ... quite a bit to humans. That,s because the study ...
... why people who eat more fruit and vegetables may gain ... that a fragment released from pectin, found in all fruits ... 3 (Gal3), a protein that plays a role in all ... effects of foods are based on population studies," says Professor ...
... TALLAHASSEE, Fla. -- In a groundbreaking study led by ... have discovered that as embryonic stem cells turn into ... the order in which DNA is replicated and reorganized. ... stem cell biologists, enabling them to better understand the ...
Cached Biology News:Scientists trace molecular origin of proportional development 2Scientists trace molecular origin of proportional development 3Pectin power 2Landmark study unlocks stem cell, DNA secrets to speed therapies 2Landmark study unlocks stem cell, DNA secrets to speed therapies 3
... Microarrays designed for RNA aptamer screening ... flexible and powerful Paraflo microfluidic on-chip synthesis ... can be synthesized on-chip and LC Sciences ... These microarrays are available as part of ...
... LX80L is an extension of Parkers MX80 family ... compact cross-section. LX80L bolt hole patterns mimic the ... units and all accessory brackets to build multi-axis ... travel to 750 mm , Accelerations to 5 ...
... is compatible with BioTeks microplate washers, ... of use and walkaway automation are ... When used with the ELx405 washer ... Bio-Stacks small footprint fits easily in ...
... the use of small interfering RNA (siRNA) ... RNA interference (RNAi) pathway have generated tremendous ... fields. siRNA for experimental use can be ... and then transfected into the target cells ...
Biology Products: